Washington
+919359902383
+919359902383

Wholesale Sunitinib 12.5 mg USA | Certified Indian Pharmaceutical Exporter | Ernest Impex

Svitinib 12.5 mg Capsule: Advanced Multi-Kinase Inhibitor for Global Oncology Sourcing


Are you searching for a verified Svitinib 12.5 mg Capsule exporter from IndiaErnest Impex, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced targeted therapies. We facilitate a secure, high-standard supply chain for Washington, London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical oncology treatments reach healthcare institutions with 100% pharmaceutical integrity.




Detailed Product Profile: What is Svitinib 12.5 mg?


Svitinib 12.5 mg is an oral targeted therapy containing the active pharmaceutical ingredient Sunitinib. This medication belongs to a class of medicines known as multi-kinase inhibitorsIt is a potent anti-cancer medication engineered to interfere with the signaling pathways that cancer cells use to grow, divide, and develop the blood vessels they need to survive.


1. Therapeutic Indications


Svitinib 12.5 mg is clinically utilized globally for the treatment of the following:

  • Renal Cell Carcinoma (RCC): Used for advanced or metastatic kidney cancer and as an adjuvant treatment for those at high risk of recurrence following surgery.

  • Gastrointestinal Stromal Tumors (GIST): Specifically for patients whose disease has progressed or who are intolerant to Imatinib.

  • Pancreatic Neuroendocrine Tumors (pNET): For the treatment of progressive, well-differentiated pNET in patients with unresectable, locally advanced, or metastatic disease.

  • Targeted Blockade: It also shows efficacy in specific cases of medullary thyroid cancer and other advanced malignancies.


2. Mechanism of Action: Multi-Targeted Strategy

Svitinib works through a sophisticated mechanism known as Multi-Tyrosine Kinase Inhibition:

  • Anti-Angiogenesis: It inhibits Vascular Endothelial Growth Factor Receptors (VEGFR) and Platelet-Derived Growth Factor Receptors (PDGFR). This action "starves" the tumor by blocking the formation of new blood vessels that provide oxygen and nutrients.

  • Growth Signal Interruption: By blocking receptors like KIT and FLT3, Svitinib halts the internal signaling pathways that tell cancer cells to multiply rapidly.

  • Metastasis Prevention: This targeted approach not only prevents further growth but actively inhibits the tumor's ability to spread to other parts of the body.

3. Administration and Dosing

  • Usage: Taken once daily, typically with a glass of water. It can be taken with or without food.

  • Consistency: To maintain steady levels in the system, it should be taken around the same time each day.

  • Dose Titration: The 12.5 mg strength is critical for achieving precise daily dosages (such as 25 mg, 37.5 mg, or 50 mg) as required by specific clinical protocols.

  • Handling: Capsules must be swallowed whole; they should not be crushed, chewed, or opened due to safety precautions.



Clinical Side Effects & Safety Monitoring


Patients on Svitinib 12.5 mg require regular medical supervision to manage potential side effects:

  • Hematological Toxicity: Potential for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets). Regular blood counts are mandatory.

  • Hypertension: High blood pressure is common; monitoring is required throughout the treatment period.

  • Hepatotoxicity: Rare but serious liver damage; periodic liver function tests (LFTs) are mandatory.

  • Dermatological: Potential for skin discoloration, hair color changes, or Hand-Foot Syndrome (redness or pain on palms and soles).

  • Thyroid Function: Potential for hypothyroidism, requiring routine thyroid-stimulating hormone (TSH) monitoring.



Why source Svitinib 12.5 mg from Ernest Impex?


In 2026, international pharmaceutical procurement relies on supply chain resilience and verified traceability. Ernest Impex offers:

  • Verified Authenticity: Direct sourcing of Svitinib with full batch-specific traceability and COA.

  • Logistics Authority: Expert handling of complex import/export regulations for the USA, UK, Thailand, Australia, Singapore, and Jamaica.

  • Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors.

  • Regulatory Compliance: Every shipment includes GMP certificates and complete B2B documentation to ensure the highest global standards.



πŸ“ž Contact Ernest Impex β€” Pharmaceutical Exporter from India


[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]


🌐 Websites:

πŸ“§ Email: exports@ernestpharmaceuticals.com

πŸ“¦ Business Type: Exporter | Bulk Supplier | Distributor

πŸ“² WhatsApp: +91 93599 02383 

πŸ”— Direct Link: Chat on WhatsApp

 2026-05-02T08:04:46

Keywords